From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery.

Journal: Journal of medical Internet research
Published Date:

Abstract

Pharmaceutical development is typically a long and arduous process, but advances in artificial intelligence may help streamline each stage of this pipeline. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent innovations and their potential implications for drug discovery.

Authors

Keywords

No keywords available for this article.